Trials / Completed
CompletedNCT00426478
Safety and Efficacy of Valsartan Plus Hydrochlorothiazide and Amlodipine in Hypertensive Patients
The Comparison of the Antihypertensive Efficacy and Tolerability Between Valsartan Plus Hydrochlorothiazide 80mg/12.5mg and Amlodipine 5mg in the Essential Hypertensive Patients
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- Sponsor
- Novartis · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A double-blind, active-controlled, randomized trial to compare Valsartan plus Hydrochlorothiazide 80mg/12.5mg and Amlodipine 5 mg. Study design: 2 weeks washout, 8 weeks treatment period.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Valsartan plus Hydrochlorothiazide (80mg/12.5mg) | |
| DRUG | Amlodipine (5mg) |
Timeline
- Start date
- 2006-11-01
- Completion
- 2007-09-01
- First posted
- 2007-01-24
- Last updated
- 2008-08-22
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT00426478. Inclusion in this directory is not an endorsement.